Andrea Tettamanti

Dr. Andrea Tettamanti

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2020 in JAMA
Verified
Journal Article
Open access
PDF file
CSChiara Sartini
Chiara Sartini
MTMoreno Tresoldi
Moreno Tresoldi
PSPaolo Scarpellini
Paolo Scarpellini
ATAndrea Tettamanti
Andrea Tettamanti
FCFrancesco Carcò
Francesco Carcò
AZAlberto Zangrillo
Alberto Zangrillo
The pandemic of coronavirus disease 2019 (COVID-19), with a large number of patients requiring respiratory support, threatens to overload intensive care units (ICUs). Noninvasive ventilation (NIV) use in general wards may be an alternative for some patients but has seldom been described and is not used worldwide.1 One study described the feasibility of NIV in the prone position2; pronation can recruit dorsal lung regions and drain airway secretions, improving gas exchange and survival in acute respiratory distress syndrome (ARDS).3 We report respiratory parameters after using this intervention in a case series of patients with COVID-19.

5 November 2015 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
GCGiulio Cossu
Giulio Cossu
SPStefano Previtali
Stefano Previtali
SNSara Napolitano
Sara Napolitano
MCMaria Pia Cicalese
Maria Pia Cicalese
FTFrancesco Saverio Tedesco
Francesco Saverio Tedesco
FCFabio Ciceri
Fabio Ciceri
Intra‐arterial transplantation of mesoangioblasts proved safe and partially efficacious in preclinical models of muscular dystrophy. We now report the first‐in‐human, exploratory, non‐randomized open‐label phase I–IIa clinical trial of intra‐arterial HLA‐matched donor cell transplantation in 5 Duchenne patients. We administered escalating doses of donor‐derived mesoangioblasts in limb arteries under immunosuppressive therapy (tacrolimus). Four consecutive infusions were performed at 2‐month intervals, preceded and followed by clinical, laboratory, and muscular MRI analyses. Two months after the last infusion, a muscle biopsy was performed. Safety was the primary endpoint. The study was relatively safe: One patient developed a thalamic stroke with no clinical consequences and whose correlation with mesoangioblast infusion remained unclear. MRI documented the progression of the disease in 4/5 patients. Functional measures were transiently stabilized in 2/3 ambulant patients, but no functional improvements were observed. Low level of donor DNA was detected in muscle biopsies of 4/5 patients and donor‐derived dystrophin in 1. Intra‐arterial transplantation of donor mesoangioblasts in human proved to be feasible and relatively safe. Future implementation of the protocol, together with a younger age of patients, will be needed to approach efficacy. Synopsis This study reports a safe, first‐in‐human mesoangioblast cell therapy to treat Duchenne muscular dystrophy (DMD) in 5 young patients, using a successful preclinical strategy, as an exploratory non‐randomized open‐label phase I–IIa clinical trial of intra‐arterial HLA‐matched donor cell transplantation. Five patients affected by DMD were treated by intra‐arterial infusions of escalating doses of HLA‐matched donor mesoangioblasts. The trial was overall safe but showed minimal, if any, efficacy. Data analysis suggested to treat patients at an earlier stage of the disease, optimize in in vitro models each single step of the transplantation protocol, and use genetically corrected, autologous mesoangioblasts in a future trial.

1 April 2013 in Neuroscience Letters
Verified
Journal Article
Closed access
RGR. Gatti
R. Gatti
ATAndrea Tettamanti
Andrea Tettamanti
PGP.M. Gough
P.M. Gough
ERE. Riboldi
E. Riboldi
LML. Marinoni
L. Marinoni
GBGiovanni Buccino
Giovanni Buccino

1 April 2020 in Journal of Rehabilitation Medicine
Verified
Journal Article
Closed access
LBLuigia Brugliera
Luigia Brugliera
ASAlfio Spina
Alfio Spina
PCP Castellazzi
P Castellazzi
PCP Cimino
P Cimino
ATAndrea Tettamanti
Andrea Tettamanti
SIS Iannaccone
S Iannaccone

1 March 2015 in Behavioural Brain Research
Verified
Journal Article
Open access
JGJavier J. Gonzalez-Rosa
Javier J. Gonzalez-Rosa
FNFabrizio Natali
Fabrizio Natali
ATAndrea Tettamanti
Andrea Tettamanti
MCMarco Cursi
Marco Cursi
SVSvetla Velikova
Svetla Velikova
Letizia LeocaniLetizia Leocani
Letizia Leocani
Motor imagery (MI) and action observation (AO) are considered effective cognitive tools for motor learning, but little work directly compared their cortical activation correlate in relation with subsequent performance. We compared AO and MI in promoting early learning of a complex four-limb, hand-foot coordination task, using electroencephalographic (EEG) and kinematic analysis. Thirty healthy subjects were randomly assigned into three groups to perform a training period in which AO watched a video of the task, MI had to imagine it, and Control (C) was involved in a distracting computation task. Subjects were then asked to actually perform the motor task with kinematic measurement of error time with respect to the correct motor performance. EEG was recorded during baseline, training and task execution, with task-related power (TRPow) calculation for sensorimotor (alpha and beta) rhythms reactive with respect to rest. During training, the AO group had a stronger alpha desynchronization than the MI and C over frontocentral and bilateral parietal areas. However, during task execution, AO group had greater beta synchronization over bilateral parietal regions than MI and C groups. This beta synchrony furthermore demonstrated the strongest association with kinematic errors, which was also significantly lower in AO than in MI. These data suggest that sensorimotor activation elicited by action observation enhanced motor learning according to motor performance, corresponding to a more efficient activation of cortical resources during task execution. Action observation may be more effective than motor imagery in promoting early learning of a new complex coordination task.

16 June 2016 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
PDF file
CGClaudia Godi
Claudia Godi
AAAlessandro Ambrosi
Alessandro Ambrosi
FNFrancesca Nicastro
Francesca Nicastro
SPStefano Previtali
Stefano Previtali
CSCorrado Santarosa
Corrado Santarosa
LPLetterio S. Politi
Letterio S. Politi
Objective: The aim of this study was to evaluate the usefulness of magnetic resonance imaging ( MRI ) in detecting the progression of Duchenne muscular dystrophy ( DMD ) by quantification of fat infiltration ( FI ) and muscle volume index ( MVI , a residual‐to‐total muscle volume ratio). Methods: Twenty‐six patients (baseline age: 5–12 years) with genetically proven DMD were longitudinally analyzed with lower limb 3T MRI , force measurements, and functional tests (Gowers, 10‐m time, North Star Ambulatory Assessment, 6‐min walking test). Five age‐matched controls were also examined, with a total of 85 MRI studies. Semiquantitative (scores) and quantitative MRI ( qMRI ) analyses (signal intensity ratio – SIR , lower limb MVI , and individual muscle MVI ) were carried out. Permutation and regression analyses according to both age and functional test‐outcomes were calculated. Age‐related quantitative reference curves of SIR s and MVI s were generated. Results: FI was present on glutei and adductor magnus in all patients since the age of 5, with a proximal‐to‐distal progression and selective sparing of sartorius and gracilis. Patients' qMRI measures were significantly different from controls' and among age classes. qMRI were more sensitive than force measurements and functional tests in assessing disease progression, allowing quantification also after loss of ambulation. Age‐related curves with percentile values were calculated for SIR s and MVI s, to provide a reference background for future experimental therapy trials. SIR s and MVI s significantly correlated with all clinical measures, and could reliably predict functional outcomes and loss of ambulation. Interpretations: qMRI ‐based indexes are sensitive measures that can track the progression of DMD and represent a valuable tool for follow‐up and clinical studies.